Breast cancer incidence and hormone therapy use before and after the Women's Health Initiative (WHI) estrogen (E) plus progestin (P) trial by race/ethnicity

被引：0
|
作者：
Chlebowski, Rowan T. [1 ]
Aragaki, Aaron K. [2 ]
Anderson, Garnet L. [2 ]
Prentice, Ross L. [2 ]
机构：
[1] Harbor UCLA Med Ctr, Torrance, CA 90509 USA
[2] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-LB-170
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-170
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Hormone therapy use after the Women's Health Initiative
    MacLennan, AH
    Taylor, AW
    Wilson, DH
    CLIMACTERIC, 2004, 7 (02) : 138 - 142
  • [42] Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial - Comments
    Tucker, G
    CLIMACTERIC, 2003, 6 (04) : 310 - 312
  • [43] Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial - Reply
    Shapiro, S
    CLIMACTERIC, 2003, 6 (04) : 313 - 313
  • [44] Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women - The Women's Health Initiative Memory Study: A randomized controlled trial
    Shumaker, SA
    Legault, C
    Rapp, SR
    Thal, L
    Wallace, RB
    Ockene, JK
    Hendrix, SL
    Jones, BN
    Assaf, AR
    Jackson, RD
    Kotchen, JM
    Wassertheil-Smoller, S
    Wactawski-Wende, J
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (20): : 2651 - 2662
  • [45] Estrogen plus progesterone and colorectal cancer incidence and mortality in the Women's Health Initiative
    Simon, Michael S.
    Chlebowski, Rowan T.
    Wactawski-Wende, Jean
    Johnson, Karen C.
    Muskovitz, Andrew
    Kato, Ikuko
    Young, Alicia
    Hubbell, F. Allan
    CANCER RESEARCH, 2012, 72
  • [46] Use of hormone replacement therapy by postmenopausal women after publication of the women's health initiative trial
    Ness, J
    Aronow, WS
    Newkirk, E
    McDanel, D
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2005, 60 (04): : 460 - 462
  • [47] Women's use of hormone therapy before and after the Women's Health Initiative: A psychosocial model of stability and change
    Gerend, Mary A.
    Aiken, Leona S.
    Erchull, Mindy J.
    Lapin, Angela
    PREVENTIVE MEDICINE, 2006, 43 (03) : 158 - 164
  • [48] Can the increase in breast cancer observed in the estrogen plus progestin arm of the Women's Health Initiative trial be explained by progesterone receptor membrane component 1?
    Stanczyk, Frank Z.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2011, 18 (08): : 833 - 834
  • [49] The use of hormone replacement therapy and natural hormones before and after the Women's Health Initiative study
    Ashby, SM
    Avellanet, YR
    Aponte, M
    Rivera, C
    Romaguera, J
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (06): : 603 - 603
  • [50] Estrogen Plus Progestin and Colorectal Cancer: Long-Term Findings From the Women's Health Initiative Randomized Clinical Trial
    Chlebowski, Rowan T.
    Aragaki, Aaron K.
    Pan, Kathy
    Luo, Juhua
    Rohan, Thomas E.
    Johnson, Karen C.
    Wactawski-Wende, Jean
    Jung, Su Yon
    Xiao, Qian
    Lavasani, Sayeh
    Manson, JoAnn E.
    Simon, Michael S.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (30)
12345